Fully automated viability and toxicity screening—A reliable all‐in‐one attempt

Abstract Background The CRISPR/Cas9 technology is nowadays a common tool for genome editing to achieve new insights into, for example, diagnostics and therapeutics in cancer and genetic disorders. Cell proliferation and anticancer drug response studies are widely used to evaluate the impact of editi...

Full description

Bibliographic Details
Published in:Cancer Medicine
Main Authors: Victoria Liedtke, Romano Weiss, Anastasia Skifov, Stefan Rödiger, Lysann Schenk
Format: Article
Language:English
Published: Wiley 2024-06-01
Subjects:
Online Access:https://doi.org/10.1002/cam4.7392